Emerging markets fall behind their developed-world counterparts
While developed-world markets look forward to a recovery, emerging market stocks have tumbled as foreign investors pull out cash.

The world is heading for a two-speed recovery, says Tom Rees in The Daily Telegraph. The world’s low and middle-income nations are “at the back of the queue for vaccines” and have little cash left to spare on fiscal stimulus.
The International Monetary Fund projects that by 2024 GDP in emerging Asia (except China) will be nearly 8% lower than it would have been without Covid-19. Latin America is on course for a 6% shortfall and sub-Saharan African economies will still be 5% smaller than the pre-pandemic trend. By contrast, advanced economies will be only 1% smaller.
In recent decades “we have got used” to the idea that global economic growth is driven by emerging economies, writes David Smith in The Sunday Times. But the pandemic has “tilted” things “back in favour of the West”.
MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
The MSCI Emerging Markets (EM) index has tumbled by 8.5% since the middle of February. That is partly due to China: the withdrawal of stimulus has hit the country’s stockmarket, with the key CSI 300 down by 6% so far this year. Chinese shares make up more than a third of the MSCI EM index.
Foreign investors are pulling out cash, reports Anna Hirtenstein in The Wall Street Journal. Investors withdrew about $3bn from EM bonds in February and then again in March. South African, Indonesian and Indian debt have suffered the biggest reverses. Money managers also withdrew $670m from developing-country stocks in the same period. Rising bond yields in America mean investors now have less incentive to risk their capital in emerging markets, which are regarded as less stable than the developed world.
Long Covid
The situation in Africa is especially concerning, says Philip Aldrick in The Times. While the continent has performed relatively well in terms of pandemic mortality, Africa faces “its own pernicious strain of long Covid-19; weak growth, unsustainable debt” and rising poverty. The World Bank says that 40 of the world’s 74 poorest nations “are at high risk of debt distress”. That number will only rise.
A huge spike in Covid-19 in India threatens to sink its recovery, report Benjamin Parkin and Amy Kazmin the Financial Times. Infections have already topped last year’s peak. Hospitals in Mumbai and other big cities risk being overwhelmed. Politicians are bringing in localised restrictions, although there is little appetite for a repeat of last year’s strict national lockdown.
The situation in India is now “a major cause for concern”, says a note from Gavekal Research. In Brazil a spiralling public health and political crisis risks turning into an economic one. “Domestic activity in much of the developing world will remain disrupted through the rest of 2021.”
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
Alex is an investment writer who has been contributing to MoneyWeek since 2015. He has been the magazine’s markets editor since 2019.
Alex has a passion for demystifying the often arcane world of finance for a general readership. While financial media tends to focus compulsively on the latest trend, the best opportunities can lie forgotten elsewhere.
He is especially interested in European equities – where his fluent French helps him to cover the continent’s largest bourse – and emerging markets, where his experience living in Beijing, and conversational Chinese, prove useful.
Hailing from Leeds, he studied Philosophy, Politics and Economics at the University of Oxford. He also holds a Master of Public Health from the University of Manchester.
-
What is the 7 year inheritance tax rule and how does it help cut your bill?
Speculation is rife chancellor Rachel Reeves has plans to target inheritance tax once again in her upcoming Budget. But the 7 year inheritance tax rule can save you thousands - here’s how it works.
-
HMRC confirms crypto ETN ISA rules
With crypto ETNs now technically available for UK retail investors, HMRC has confirmed they can be held in an ISA – but there’s a complication
-
Pierre-Édouard Stérin wants to make France great again
Conservative billionaire Pierre-Édouard Stérin is seeking to lead a political and spiritual renaissance across the Channel. The planning looks meticulous
-
Global investors have overlooked the top innovators in emerging markets
Opinion Carlos Hardenberg, portfolio manager, Mobius Investment Trust, highlights three emerging market stocks where he’d put his money
-
Pinewood Technologies: a drive for growth
Pinewood Technologies’ platform is one of the best in the business. Investors should buy in
-
'EV maker Faraday Future will crash'
Faraday Future Intelligent Electric is failing dismally to live up to its name, says Matthew Partridge
-
Investors should cheer the coming nuclear summer
The US and UK have agreed a groundbreaking deal on nuclear power, and the sector is seeing a surge in interest from around the world. Here's how you can profit
-
8 of the best houses for sale with follies
The best houses for sale with follies in the grounds – from a five-storey Victorian Gothic tower in Tonbridge, Kent, to a former mill in Oxfordshire with gardens that include a folly on an island in a lake
-
A tale of two Reits – why performance matters for valuation
AEW UK and Regional are two Reits that are valued very differently, despite a shared focus on properties outside London
-
Healthcare stocks look cheap, but tread carefully
Shares in healthcare companies could get a shot in the arm if uncertainty over policy in the US wanes, but are they worth the risk?